In the pathophysiological process of AD, oxidative stress activates and increases the activation of microglia and astrocytes, thereby activating NF-κB, which is closely related to β-secretase activity and tau protein metabolism in the brain of AD patients. Here, NFKB1 is linked to Alzheimer disease.